Multiple Primary Malignant Neoplasms: An Unusual Case of Metachronous Breast Ductal and Squamous Cell Carcinomas.

breast cancer multiple primary malignant neoplasms squamous cell cancer

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
11 Feb 2020
Historique:
entrez: 20 3 2020
pubmed: 20 3 2020
medline: 20 3 2020
Statut: epublish

Résumé

Multiple primary malignant neoplasms (MPMN) are generally defined as the co-occurrence of multiple primary malignant neoplasms of distinct histology in the same individual. Second and higher-order primary malignancies now comprise about 18% of all incidence of cancer in the USA. The incidence ratio of developing multiple primary cancers (MPCs) in female cancer survivors is 1.17 to 1.6. In women with breast cancer, the incidence ratio is even higher, according to age at diagnosis of breast cancer. However, the concurrence of breast cancer and squamous cell carcinoma is not described in the literature. Primary squamous cell carcinoma of bone is also rare in the skeletal system other than in the skull, with only three such cases reported in the English literature. We present a case of a 59-year-old woman with high-grade primary invasive ductal carcinoma of the breast and second distinct squamous cell carcinoma metastasis to the bone of unknown primary site. A search for a primary squamous cell carcinoma, including CT head and neck, CT chest, colposcopy, esophagogastroduodenoscopy (EGD) and colonoscopy, did not show any evidence of a primary site.

Identifiants

pubmed: 32190504
doi: 10.7759/cureus.6954
pmc: PMC7067516
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e6954

Informations de copyright

Copyright © 2020, Ibrahim et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):359-63
pubmed: 17379448
J Indian Med Assoc. 1997 Sep;95(9):521, 523
pubmed: 9529591
Radiother Oncol. 2006 Jun;79(3):310-5
pubmed: 16766067
J Korean Med Sci. 2013 May;28(5):651-7
pubmed: 23678254
Eur J Cancer. 2005 Oct;41(15):2304-11
pubmed: 16140006
Nat Rev Clin Oncol. 2013 May;10(5):289-301
pubmed: 23529000
Am J Clin Oncol. 2003 Feb;26(1):79-83
pubmed: 12576929
Clin Orthop Relat Res. 2009 Dec;467(12):3346-50
pubmed: 19526272
Acta Otolaryngol. 2005 Jun;125(6):678-82
pubmed: 16076722
Cancer. 2004 Jun 15;100(12):2613-21
pubmed: 15197804
Breast Cancer Res Treat. 2000 Jun;61(3):183-95
pubmed: 10965995

Auteurs

Mohd Elmugtaba Ibrahim (ME)

Internal Medicine, Howard University Hospital, Washington, D.C., USA.

Mohammed Saleh (M)

Internal Medicine, Howard University Hospital, Washington, D.C., USA.

Ahmed Ali (A)

Oncology, Howard University Hospital, Washington, D.C., USA.

Navid Alavi (N)

Internal Medicine, Howard University Hospital, Washington, D.C., USA.

Classifications MeSH